Markets:

Overview

News

Currencies

International

Treasuries

Lantern Pharma Inc. - Common Stock (NQ:LTRN)

1.370 +0.130 (+10.48%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Lantern Pharma Inc. - Common Stock

< Previous 1 2 3 4 Next >

Discover the top movers in Tuesday's pre-market session. ↗

March 31, 2026

Via Chartmill

These stocks have an unusual volume in today's session ↗

March 30, 2026

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 13, 2025

Via Benzinga

Lantern Pharma Earnings Preview ↗

November 12, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

September 30, 2025

As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Lantern Pharma's Earnings Outlook ↗

May 14, 2025

Via Benzinga

Preview: Lantern Pharma's Earnings ↗

March 26, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 14, 2025

Via Benzinga

Lantern Pharma Narrows Loss in Q2 ↗

August 13, 2025

Via The Motley Fool

Topics Artificial Intelligence

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 16, 2025

Via Benzinga

EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients ↗

May 12, 2025

Lantern Pharma receives FDA clearance to begin Phase 1b/2 trial of LP-184 in advanced NSCLC patients with key mutations and low PD-L1 expression.

Via Benzinga

Earnings Scheduled For May 15, 2025 ↗

May 15, 2025

Via Benzinga

EXCLUSIVE: Lantern Advances Breast Cancer Drug Candidate With FDA Clearance For Early-Stage Trial ↗

May 05, 2025

Lantern Pharma's LP-184 advances to Phase 1b/2 trial in TNBC after FDA clearance, adding to its Fast Track and Rare Pediatric Disease designations.

Via Benzinga

Earnings Scheduled For March 27, 2025 ↗

March 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 13, 2024

Via Benzinga

LTRN Stock Earnings: Lantern Pharma Beats EPS for Q2 2024 ↗

August 08, 2024

LTRN stock results show that Lantern Pharma beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 13, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 10, 2024

Via Benzinga

LTRN Stock Earnings: Lantern Pharma Misses EPS for Q1 2024 ↗

May 09, 2024

LTRN stock results show that Lantern Pharma missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

3 Machine Learning Stocks with the Potential to Make You an Overnight Millionaire ↗

May 01, 2024

Keep an eye on machine learning stocks. With big demand, we could be looking at a half-trillion-dollar market by 2030.

Via InvestorPlace

Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket ↗

April 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 11, 2024

Via Benzinga

AI Sector Stalling: Only 4 Of 7 Categories Went Up In March ↗

March 31, 2024

No AI category went down in February, but 3 did in March - confirming my comment last week that

Via Talk Markets

Topics Artificial Intelligence

Six Of Seven AI Stock Categories Increased This Week ↗

March 23, 2024

All but one of the 7 artificial intelligence stock categories that I analyze weekly increased in value this week. But two categories are still down MTD, suggesting that the surge in the artificial...

Via Talk Markets

Topics Artificial Intelligence

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 19, 2024

Via Benzinga

LTRN Stock Earnings: Lantern Pharma Beats EPS for Q4 2023 ↗

March 18, 2024

LTRN stock results show that Lantern Pharma beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.